Guidelines on “Similar Biologics: Regulatory requirements for Market Authorization in India” will be implemented from 15th September 2012.
The “Guidelines on Similar Biologics” prepared by Central Drugs Standard Control Organization (CDSCO) and the Department of Biotechnology (DBT) lay down the regulatory pathway for a similar biologic claiming to be similar to an already authorized reference biologic.
The guidelines address the regulatory pathway regarding manufacturing process and quality aspects for similar biologics.
These guidelines also address the pre-market regulatory requirements including comparability exercise for quality, preclinical and clinical studies and post market regulatory requirements for similar biologics.
For further details visit
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTU0NA==
Recent Posts
How to Manufacture Class A & B Medical Devices in India: State FDA License Guide
A quick guide on the Class A & B Medical Device manufacturing license — covering State FDA rules, Form MD-3/MD-5, fees, and timelines for manufacturers. Every manufacturer entering India’s..
Importing Small Quantities of Cosmetics for R&D in India: NOC Requirements
A brief guide on Cosmetic import NOC India — covering when small quantity Cosmetic import for R&D testing bypasses full registration under Cosmetic rules 2020. Not every Cosmetic shipment into I..
The Cosmeceuticals Grey Zone: When a Cosmetic Claim Risks Becoming a Drug Claim
“Cosmeceutical” is a popular marketing word. It suggests something more powerful than an ordinary Cosmetic — a product that treats skin condition, not just improves appearance. The problem is th..
Get In Touch With Our Team
-
Email: contact@cliniexperts.com
-
Timings: 9 am to 6 pm (Monday to Friday)
-
Location: India: Delhi, Bangalore Global: USA, Singapore